cas 615-13-4|| where to buy 1H-Inden-2(3H)-one

Nom du produit:1H-Inden-2(3H)-one

IUPAC Name:2,3-dihydro-1H-inden-2-one

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM254045-500g	in stock	Ǌǯƞ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 615-13-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:615-13-4; Formule moléculaire:C9H8O; Point de fusion:-; Code SMILES:O=C1CC2=C(C=CC=C2)C1; Densité:

: Numéro de catalogue:CM254045; Poids moléculaire:132.16; Point d'ébullition:248.9°C at 760 mmHg; N° Mdl:MFCD00003792; Stockage:Keep in inert atmosphere, store at 2-8°C.

: Indenes; Indenes are useful building blocks found in a variety of biologically relevant products.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: BNC-210; Bionomics Ltd.’s drug candidate, BNC-210 would be advanced into Phase 3 studies in Social Anxiety Disorder (SAD) after the successful End-of-Phase 2 Meeting with the U.S. FDA in September. BNC-210 has a unique action potential that depends on acetylcholine neurotransmission and allosteric modulation of α7 nAChR. It is designed to treat patients with serious central nervous system (CNS) disorders with limited side effects. BNC-210 received Fast-Track designation from the FDA for the acute treatment of SAD.